Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
The Financial Times today cited sources as saying that OpenAI Chief Executive Sam Altman is participating in the investment.
ENDPOINTS NEWS13d
With Sam Alt­man’s help, Retro Bio­sciences eyes $1B to ex­tend lifes­pan by 10 years
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
newsbytesapp.com13d
Sam Altman-backed start-up is raising $1B to extend human lifespan
OpenAI CEO Sam Altman backs Retro Biosciences, a San Francisco-based biotech start-up that wants to extend human lifespan by ...
Daily Digest: AI founder indicted; Sam Altman backs life-extending biotech
What's trending in Bay Area business news this Friday morning: Twilio, EA Sports, Headlands Brewing, GameOn, 345 California, Retro Biosciences and more.
glassalmanac.com7d
Sam Altman Unveils Unexpected Scientific Breakthroughs Through AI
OpenAI, in partnership with Retro Biosciences, has recently made significant strides in human longevity research with the ...
Sam Altman-Backed Retro Biosciences Raising $1 Billion to Extend Human Lifespan
Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...